T-lymphoblastic lymphoma/leukemia (T-LBL) is a neoplasm of immature lymphoid cells (lymphoblasts) committed to the T-cell lineage. The disease usually presents as an extramedullary tumor mass in the anterior mediastinum or lymph nodes (T-LBL). A smaller subset of patients present with predominant blood and bone marrow involvement (T-lymphoblastic leukemia [T-ALL]). Patients who present as T-LBL often convert to a T-ALL clinical picture over time. This clinical overlap, as well as overlap in immunophenotypic and molecular features, led the authors of the World Health Organization (WHO) classification to combine T-ALL and T-LBL cases into one category. There are some immunophenotypic and molecular differences between T-ALL and T-LBL, however, that may explain their different clinical presentations. Here we focus on patients presenting as T-LBL.
KeywordsLactate Tyrosine Leukemia CD117 Cough
- 1.Borowitz MJ, Chan JKC. T lymphoblastic leukemia/lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. p. 176–8.Google Scholar
- 14.Ferrando AA. The role of NOTCH1 signaling in T-ALL. Hematology Am Soc Hematol Educ Program. 2009;353–61.Google Scholar